Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential discoveries into new therapeutic approaches. Current focus centers on targeting the underlying mechanisms of MSA. One strategy under investigation involves pharmacological interventions to influence the dysre